Crossmark

Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation

Crossref DOI link: https://doi.org/10.1038/s41409-020-01022-x

Published Online: 2020-08-08

Published Print: 2021-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stamouli, Maria

Tsonis, Ioannis

Gkirkas, Konstantinos

Economopoulou, Christina

Siafakas, Nikolaos

Pournaras, Spyridon

Antoniadou, Anastasia

Chondropoulos, Spyros

Karagiannidi, Angeliki

Meletiadis, Josef https://orcid.org/0000-0002-8869-1509
Gigantes, Stavros

Baltadakis, Ioannis

Goussetis, Evgenios

Karakasis, Dimitrios

Tsirigotis, Panagiotis https://orcid.org/0000-0002-3522-3680
License Information

Text and Data Mining valid from 2020-08-08

Version of Record valid from 2020-08-08
More Information

Article History

Received: 24 March 2020

Revised: 22 July 2020

Accepted: 29 July 2020

First Online: 8 August 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below